{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:35:15Z","timestamp":1791218115672,"version":"4.1.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.2215\/cjn.09660914","type":"journal-article","created":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T08:47:49Z","timestamp":1427878069000},"page":"740-749","source":"Crossref","is-referenced-by-count":26,"title":["Association of Serum Ig Free Light Chains with Mortality and ESRD among Patients with Nondialysis-Dependent CKD"],"prefix":"10.2215","volume":"10","author":[{"given":"James","family":"Ritchie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakhvir K.","family":"Assi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Burmeister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Hoefield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Cockwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip A.","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20230601","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1001\/jama.2011.468","article-title":"Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality.","volume":"305","author":"Peralta","year":"2011","journal-title":"JAMA"},{"key":"R2-5-20230601","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1681\/ASN.2008070730","article-title":"Combining GFR and albuminuria to classify CKD improves prediction of ESRD.","volume":"20","author":"Hallan","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R3-5-20230601","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/ki.2010.550","article-title":"Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts.","volume":"79","author":"Astor","year":"2011","journal-title":"Kidney Int"},{"key":"R4-5-20230601","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1440-1797.2009.01119.x","article-title":"Review article: Biomarkers of clinical outcomes in advanced chronic kidney disease.","volume":"14","author":"Kovesdy","year":"2009","journal-title":"Nephrology (Carlton"},{"key":"R5-5-20230601","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/ki.2011.198","article-title":"Biomarkers in chronic kidney disease: A review.","volume":"80","author":"Fassett","year":"2011","journal-title":"Kidney Int"},{"key":"R6-5-20230601","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2215\/CJN.03670807","article-title":"Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: How do new pieces fit into the uremic puzzle?","volume":"3","author":"Stenvinkel","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R7-5-20230601","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis.","volume":"375","author":"Matsushita","year":"2010","journal-title":"Lancet"},{"key":"R8-5-20230601","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/ki.2008.75","article-title":"Inflammation and cardiovascular events in individuals with and without chronic kidney disease.","volume":"73","author":"Weiner","year":"2008","journal-title":"Kidney Int"},{"key":"R9-5-20230601","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1046\/j.1523-1755.63.s84.8.x","article-title":"Immunoglobulin light chains in uremia.","volume":"84","author":"Cohen","year":"2003","journal-title":"Kidney Int Suppl"},{"key":"R10-5-20230601","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3410\/M5-4","article-title":"Polyclonal free light chains: A biomarker of inflammatory disease or treatment target?","volume":"5","author":"Brebner","year":"2013","journal-title":"F1000 Med Rep"},{"key":"R11-5-20230601","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.2215\/CJN.02290508","article-title":"Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease.","volume":"3","author":"Hutchison","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R12-5-20230601","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1136\/jclinpath-2012-200910","article-title":"Elevated, combined serum free light chain levels and increased mortality: A 5-year follow-up, UK study.","volume":"65","author":"Anandram","year":"2012","journal-title":"J Clin Pathol"},{"key":"R13-5-20230601","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.mayocp.2012.03.009","article-title":"Use of nonclonal serum immunoglobulin free light chains to predict overall survival in the general population.","volume":"87","author":"Dispenzieri","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"R14-5-20230601","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.2215\/CJN.03350411","article-title":"Serum free light chains and the risk of ESRD and death in CKD.","volume":"6","author":"Haynes","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R15-5-20230601","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.3390\/toxins5112058","article-title":"Association between free light chain levels, and disease progression and mortality in chronic kidney disease.","volume":"5","author":"Desjardins","year":"2013","journal-title":"Toxins (Basel"},{"key":"R16-5-20230601","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.mayocp.2014.01.028","article-title":"Serum polyclonal immunoglobulin free light chain levels predict mortality in people with chronic kidney disease.","volume":"89","author":"Hutchison","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"R17-5-20230601","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1053\/j.ajkd.2010.06.010","article-title":"Factors associated with kidney disease progression and mortality in a referred CKD population.","volume":"56","author":"Hoefield","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"R18-5-20230601","doi-asserted-by":"crossref","first-page":"597906","DOI":"10.1155\/2013\/597906","article-title":"Extreme elevations in blood pressure and all-cause mortality in a referred CKD population: Results from the CRISIS Study.","volume":"2013","author":"Ritchie","year":"2013","journal-title":"Int J Hypertens"},{"key":"R20-5-20230601","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation.","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"R24-5-20230601","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance.","volume":"354","author":"Kyle","year":"2006","journal-title":"N Engl J Med"},{"key":"R25-5-20230601","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1373\/clinchem.2009.126664","article-title":"Screening panels for detection of monoclonal gammopathies.","volume":"55","author":"Katzmann","year":"2009","journal-title":"Clin Chem"},{"key":"R26-5-20230601","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nrneph.2009.151","article-title":"Serum free light chain assessment in monoclonal gammopathy and kidney disease.","volume":"5","author":"Hutchison","year":"2009","journal-title":"Nat Rev Nephrol"},{"key":"R27-5-20230601","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/ki.2011.94","article-title":"The biology of immunoglobulin free light chains and kidney injury.","volume":"79","author":"Basnayake","year":"2011","journal-title":"Kidney Int"},{"key":"R28-5-20230601","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/ijlh.12159","article-title":"The relationship between high-sensitivity CRP and polyclonal free light chains as markers of inflammation in chronic disease.","volume":"36","author":"Burmeister","year":"2014","journal-title":"Int J Lab Hematol"},{"key":"R29-5-20230601","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000091806","article-title":"Positive acute-phase inflammatory markers in different stages of chronic kidney disease.","volume":"26","author":"Rom\u00e3o","year":"2006","journal-title":"Am J Nephrol"},{"key":"R30-5-20230601","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1681\/ASN.2005101085","article-title":"Chronic kidney disease and mortality risk: A systematic review.","volume":"17","author":"Tonelli","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R31-5-20230601","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/jgs.12223","article-title":"A simple tool to predict end-stage renal disease within 1 year in elderly adults with advanced chronic kidney disease.","volume":"61","author":"Drawz","year":"2013","journal-title":"J Am Geriatr Soc"},{"key":"R32-5-20230601","doi-asserted-by":"crossref","first-page":"596","DOI":"10.7326\/0003-4819-158-8-201304160-00004","article-title":"Risk prediction models for patients with chronic kidney disease: A systematic review.","volume":"158","author":"Tangri","year":"2013","journal-title":"Ann Intern Med"},{"key":"R33-5-20230601","doi-asserted-by":"crossref","first-page":"653","DOI":"10.4049\/jimmunol.0901129","article-title":"Ig-free light chains play a crucial role in murine mast cell-dependent colitis and are associated with human inflammatory bowel diseases.","volume":"185","author":"Rijnierse","year":"2010","journal-title":"J Immunol"},{"key":"R34-5-20230601","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1164\/rccm.201104-0761OC","article-title":"An association between neutrophils and immunoglobulin free light chains in the pathogenesis of chronic obstructive pulmonary disease.","volume":"185","author":"Braber","year":"2012","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201505000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:45:11Z","timestamp":1786369511000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201505000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.09660914","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]}}}